Early-access Avacopan in Real-world ANCA-associated Vasculitis
Recruiting
Observational Study
ANCA Associated Vasculitis
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 16 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 100 (estimated)
- Sponsor
- Leiden University Medical Center · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The current study proposal aims to investigate the clinical practice variation of the initial use of avacopan for AAV patients in Europe. The study will describe patient characteristics and organ-specific clinical benefit of avacopan treatment in a unique, first-experience cohort of AAV patients. By studying the clinical practice variation of first-experience avacopan treatment, this study will be…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Established diagnosis of GPA or MPA
* Treatment (initiation) with avacopan
* Informed consent for use of medical data
Exclusion Criteria:
* If there is no AAV disease activity present that can be supported by an objectifiable clinical measure or assessment
* If a subject is …
Contacts